β-D-GlcpA-(1→3)-β-D-GalpNAc4S

Metabolite details

Identifier

AVJBPWGFOQAPRH-MMPMEFKSSA-N

InChI Key

AVJBPWGFOQAPRH-MMPMEFKSSA-N

IUPAC name

2-acetamido-2-deoxy-3-O-β-D-glucopyranuronosyl-4-O-sulfo-β-D-galactopyranose

Preferred name

β-D-GlcpA-(1→3)-β-D-GalpNAc4S

INN name

—

Synonym

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

ChEBI

CHEBI:145591

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Sham_vs_Radiofrequency
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d